ATE278021T1 - Rekombinante bakterienstämme zur herstellung von natürlichen nucleosiden, sowie von modifizierten analogen davon - Google Patents

Rekombinante bakterienstämme zur herstellung von natürlichen nucleosiden, sowie von modifizierten analogen davon

Info

Publication number
ATE278021T1
ATE278021T1 AT99965565T AT99965565T ATE278021T1 AT E278021 T1 ATE278021 T1 AT E278021T1 AT 99965565 T AT99965565 T AT 99965565T AT 99965565 T AT99965565 T AT 99965565T AT E278021 T1 ATE278021 T1 AT E278021T1
Authority
AT
Austria
Prior art keywords
production
bacterial strains
recombinant bacterial
natural nucleosides
modified analogues
Prior art date
Application number
AT99965565T
Other languages
English (en)
Inventor
Giuseppina Bestetti
Simona Cali
Daniela Ghisotti
Gaetano Orsini
Giancarlo Tonon
Gabriele Zuffi
Original Assignee
Keryos Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryos Spa filed Critical Keryos Spa
Application granted granted Critical
Publication of ATE278021T1 publication Critical patent/ATE278021T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/02—Monosaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT99965565T 1998-12-23 1999-12-23 Rekombinante bakterienstämme zur herstellung von natürlichen nucleosiden, sowie von modifizierten analogen davon ATE278021T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002792A IT1304500B1 (it) 1998-12-23 1998-12-23 Ceppi batterici ricombinati per la produzione di nucleosidi naturali edi analoghi modificati.
PCT/EP1999/010416 WO2000039307A2 (en) 1998-12-23 1999-12-23 Recombinant bacterial strains for the production of natural nucleosides and modified analogues thereof

Publications (1)

Publication Number Publication Date
ATE278021T1 true ATE278021T1 (de) 2004-10-15

Family

ID=11381317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99965565T ATE278021T1 (de) 1998-12-23 1999-12-23 Rekombinante bakterienstämme zur herstellung von natürlichen nucleosiden, sowie von modifizierten analogen davon

Country Status (9)

Country Link
US (2) US6911341B2 (de)
EP (1) EP1141328B1 (de)
JP (1) JP2002533126A (de)
AT (1) ATE278021T1 (de)
AU (1) AU2103000A (de)
DE (1) DE69920749T2 (de)
ES (1) ES2229807T3 (de)
IT (1) IT1304500B1 (de)
WO (1) WO2000039307A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1304500B1 (it) * 1998-12-23 2001-03-19 Norpharma Spa Ceppi batterici ricombinati per la produzione di nucleosidi naturali edi analoghi modificati.
US7037718B2 (en) * 2001-10-26 2006-05-02 Cornell Research Foundation, Inc. Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
US7488598B2 (en) 2001-10-26 2009-02-10 Cornell Center For Technology Enterprise And Commercialization Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
ES2235638B1 (es) * 2003-12-17 2006-10-16 Cellerix, S.L. Nuevo vector retroviral de alto titulo y metodos de transduccion.
ES2343741T3 (es) * 2006-03-15 2010-08-09 Explora Laboratories Sa Un proceso para la inmovilizacion de celulas en una resina.
EP2338985A1 (de) * 2009-12-22 2011-06-29 Institut Univ. de Ciència i Tecnologia, s.a. Wärmebeständige Biokatalysatorkombination zur Nukleotidsynthese
JP2016198075A (ja) * 2015-04-14 2016-12-01 プラズミア バイオテック，エス．エル． シトシンヌクレオシドアナログの酵素産生
CN113969299B (zh) * 2021-10-17 2023-10-20 拓新药业集团股份有限公司 一种生物转化合成尿苷的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573777A (en) * 1977-11-03 1980-08-28 Wellcome Found 9-d-arabinonucleosides and an enzymatic process for their preparation
HU185928B (en) * 1980-04-23 1985-04-28 Wellcome Found Process for preparing 4-substituted-1beta-d-ribofuranosyl-1h-imidazo/4,5-c/pyridines
US4347315A (en) * 1980-04-25 1982-08-31 Burroughs Wellcome Co. Synthesis of ribosides using bacterial phosphorylase
US4835104A (en) 1987-06-16 1989-05-30 Ajinomoto Co., Inc., Patent & Licensing Department Process for producing and purifying 2',3'-dideoxynucleosides, and process for producing 2',3'-dideoxy-2',3'-didehydronucleosides
JP2619710B2 (ja) * 1989-02-27 1997-06-11 日本製紙 株式会社 ２′，３′−ジデオキシプリンヌクレオシド類の製造方法
EP0423641A3 (en) * 1989-10-18 1992-01-15 Nippon Mining Company Limited Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or tgfalpha
JPH06253854A (ja) * 1993-02-26 1994-09-13 Yamasa Shoyu Co Ltd 組換えｄｎａ手法によるヌクレオシド・ホスホリラーゼの製造法
JP4304727B2 (ja) * 1996-11-21 2009-07-29 味の素株式会社 ヌクレオシド−５’−燐酸エステルの製造法
US6229001B1 (en) * 1997-01-03 2001-05-08 Southern Research Institute Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
JPH10286097A (ja) * 1997-04-15 1998-10-27 Yamasa Shoyu Co Ltd プリンアラビノシドの酵素的製造法
JP3799784B2 (ja) 1997-11-14 2006-07-19 味の素株式会社 ２，６−ジアミノプリン−２’−デオキシリボシドおよび２’−デオキシグアノシンの製造法
IT1304500B1 (it) * 1998-12-23 2001-03-19 Norpharma Spa Ceppi batterici ricombinati per la produzione di nucleosidi naturali edi analoghi modificati.

Also Published As

Publication number Publication date
WO2000039307A3 (en) 2000-11-09
AU2103000A (en) 2000-07-31
US20030059870A1 (en) 2003-03-27
IT1304500B1 (it) 2001-03-19
EP1141328B1 (de) 2004-09-29
JP2002533126A (ja) 2002-10-08
DE69920749T2 (de) 2006-03-02
US7781189B2 (en) 2010-08-24
DE69920749D1 (de) 2004-11-04
US20050142645A1 (en) 2005-06-30
WO2000039307A2 (en) 2000-07-06
US6911341B2 (en) 2005-06-28
ES2229807T3 (es) 2005-04-16
EP1141328A2 (de) 2001-10-10
ITMI982792A1 (it) 2000-06-23

Similar Documents

Publication Publication Date Title
WO1995007718A3 (en) Purine nucleoside phosphorylase gene therapy for human malignancy
WO1998020145A3 (en) Improvements in or relating to starch content of plants
EP0905232A4 (de) Neue beta 1-4 n-acetylglucosaminyltransferase sowie das für diese kodierende gen
IT1294728B1 (it) Ceppi di lievito per la riproduzione di acido lattico
ZA914714B (en) A cell having a certain function in a process,containing recombinant dna encoding at least one enzyme,recombinant dna,enzyme for which the recombinant dna encodes and uses thereof
AU1603899A (en) Mutant (bacillus licheniformis) alpha-amylase
BR0009362A (pt) Variante de uma alfa-amilase semelhante atermamyl precursora, construção de dna, vetorde expressão recombinante, célula, composição,processo para gerar uma variante de umaalfa-amilase semelhante a termamyl precursora,e, uso de uma variante de alfa-amilase
NZ335628A (en) Improved expression vectors comprising a nucleic acid construct with tac and gal bacterial promoters
AU2126688A (en) Serum free media for the growth of insect cells and expression of products thereby
EP0841398A3 (de) Kojibiose Phosphorylase, deren Herstellung und Verwendung
AU2625895A (en) Modification of starch content in plants
WO2003035012A3 (en) Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
ATE278021T1 (de) Rekombinante bakterienstämme zur herstellung von natürlichen nucleosiden, sowie von modifizierten analogen davon
DE69734669D1 (de) Enzymatische cofaktor-regeneration unter verwendung von pyridin-nucleotid transhydrogenase
AR011501A1 (es) Una secuencia de nucleotidos aislada que codifica la 17 beta- hidroxiesteroide dehidrogenasa de tipo 5; vector de expresion recombinante;celula huesped recombinante; secuencia de oligonucleotidos; un fragmento de adn cromosomico; metodo para producir la 17 beta-hsd de tipo 5; metodo para i
DE59812281D1 (en) Promotor aus ashbya gossypii
KR900702009A (ko) 인체 a형 모노아민 옥시다제를 코오딩 하는 dna
AU5108090A (en) Production of nucleoside
ES2059362T3 (es) Producto enzimatico de beta-amilasa, preparacion y su empleo.
ES8701224A1 (es) Un metodo para producir citidina y-o desoxicitidina
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
DK0817862T3 (da) Enzymatisk enkelt beholder-sulfateringsproces, hvor der anvendes 3'phosphoadenosin-5'phosphosulfat og genbrugte phosphorylerede adenosin-mellemprodukter
DK0751218T3 (da) Saccharose-stofskifte-mutanter
EP2281892A3 (de) Verfahren zur Herstellung von Polypeptiden in atmungsdefizienten Trichoderma Zellen
BR8403146A (pt) Enzima acido 2,5-dicetogluconico redutase,processo de preparacao de 2,5-dkg redutase,enzima e proteina com atividade de 2,5-dkg redutase,processo de conversao de 2,5-dkg em 2-klg,processo de elaboracao de veiculo de expressao replicavel,vetor e veiculo de expressao,cultura celular ou celulas hospedeiras,cultura celular ou celula recombinante,microorganismo,e processo de conversao de metabolito comum em 2-klg.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties